Dr Xuya Huang

  • Associate Clinical Fellow (Institute of Neuroscience & Psychology)

telephone: 01412012465
email: Xuya.Huang@glasgow.ac.uk

Research interests

No staff ID in DB


Publications

List by: Type | Date

Jump to: 2019 | 2018 | 2017 | 2016 | 2015
Number of items: 17.

2019

Bivard, A. et al. (2019) Comparing mismatch strategies for patients being considered for ischemic stroke tenecteplase trials. International Journal of Stroke, (doi: 10.1177/1747493019884529) (PMID:31684841) (Early Online Publication)

El-Tawil, S., Mair, G., Huang, X., Sakka, E., Palmer, J., Ford, I. , Kalra, L., Wardlaw, J. and Muir, K. W. (2019) Observer agreement on CT Perfusion imaging in acute ischemic stroke. Stroke, 50(11), pp. 3108-3114. (doi: 10.1161/STROKEAHA.119.026238) (PMID:31928512) (PMCID:PMC6824508)

Kalladka, D., Sinden, J., McLean, J., Moreton, F. C., Huang, X. and Muir, K. W. (2019) Increased deep grey matter functional connectivity of poststroke hNSC implanted ipsilesional putamen. Journal of Neurology, Neurosurgery and Psychiatry, 90(8), pp. 959-960. (doi: 10.1136/jnnp-2018-319022) (PMID:30530567)

Al-Shahi Salman, R. et al. (2019) Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial. Lancet Neurology, 18(7), pp. 643-652. (doi: 10.1016/S1474-4422(19)30184-X) (PMID:31129065)

Al-Shahi Salman, R. et al. (2019) Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial. Lancet, 393(10191), pp. 2613-2623. (doi: 10.1016/S0140-6736(19)30840-2) (PMID:31128924) (PMCID:PMC6617509)

2018

Al-Shahi Salman, R. et al. (2018) The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial. Trials, 19, 162. (doi: 10.1186/s13063-018-2542-6) (PMID:29506580) (PMCID:PMC5838871)

2017

Huang, X., Kalladka, D., Cheripelli, B. K., Moreton, F. C. and Muir, K. W. (2017) The impact of CT perfusion threshold on predicted viable and nonviable tissue volumes in acute ischaemic stroke. Journal of Neuroimaging, 27(6), pp. 602-606. (doi: 10.1111/jon.12442) (PMID:28414895)

Moreton, F. C., Düring, M., Phan, T., Srikanth, V., Beare, R., Huang, X., Jouvent, E., Chabriat, H., Dichgans, M. and Muir, K. W. (2017) Arterial branching and basal ganglia lacunes: a study in pure small vessel disease. European Stroke Journal, 2(3), pp. 264-271. (doi: 10.1177/2396987317718450)

Bivard, A. et al. (2017) Tenecteplase in ischemic stroke offers improved recanalization: analysis of 2 trials. Neurology, 89(1), pp. 62-67. (doi: 10.1212/WNL.0000000000004062) (PMID:28576782)

Bivard, A. et al. (2017) Impact of computed tomography perfusion imaging on the response to tenecteplase in ischemic stroke: analysis of two randomized controlled trials. Circulation, 135(5), pp. 440-448. (doi: 10.1161/CIRCULATIONAHA.116.022582) (PMID:27965285)

2016

El Tawil, S., Cheripelli, B., Huang, X., Moreton, F., Kalladka, D., MacDougal, N. J.J., McVerry, F. and Muir, K. W. (2016) How many stroke patients might be eligible for mechanical thrombectomy? European Stroke Journal, 1(4), pp. 264-271. (doi: 10.1177/2396987316667176)

Cheripelli, B. K., Huang, X., MacIsaac, R. and Muir, K. W. (2016) Interaction of recanalization, intracerebral hemorrhage, and cerebral edema after intravenous thrombolysis. Stroke, 47(7), pp. 1761-1767. (doi: 10.1161/STROKEAHA.116.013142) (PMID:27301943)

Huang, X. et al. (2016) Tenecteplase versus alteplase in stroke thrombolysis: an individual patient data meta-analysis of randomized controlled trials. International Journal of Stroke, 11(5), pp. 534-543. (doi: 10.1177/1747493016641112) (PMID:27048693)

Cheripelli, B. K., Huang, X., McVerry, F. and Muir, K. (2016) What is the relationship among penumbra volume, collaterals, and time since onset in the first 6 h after acute ischemic stroke? International Journal of Stroke, 11(3), pp. 338-346. (doi: 10.1177/1747493015620807) (PMID:26763919)

2015

Huang, X., Moreton, F., Kalladka, D., Cheripelli, B. K., Macisaac, R., Tait, R. C. and Muir, K. (2015) Coagulation and fibrinolytic activity of tenecteplase and alteplase in acute ischemic stroke. Stroke, 46(12), pp. 3543-3546. (doi: 10.1161/strokeaha.115.011290) (PMID:26514192)

Huang, X., Cheripelli, B. K., Lloyd, S. M. , Kalladka, D., Moreton, F. C., Siddiqui, A., Ford, I. and Muir, K. W. (2015) Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST): phase 2 randomised clinical trial. Lancet Neurology, 14(4), pp. 368-376. (doi: 10.1016/S1474-4422(15)70017-7) (PMID:25726502)

Ramani, L., Huang, X., Cheripelli, B. and Muir, K. W. (2015) Intravenous thrombolysis for acute stroke: current standards and future directions. Current Treatment Options in Cardiovascular Medicine, 17(3), 16. (doi: 10.1007/s11936-015-0373-2) (PMID:25778425)

This list was generated on Fri Aug 7 04:13:10 2020 BST.
Jump to: Articles
Number of items: 17.

Articles

Bivard, A. et al. (2019) Comparing mismatch strategies for patients being considered for ischemic stroke tenecteplase trials. International Journal of Stroke, (doi: 10.1177/1747493019884529) (PMID:31684841) (Early Online Publication)

El-Tawil, S., Mair, G., Huang, X., Sakka, E., Palmer, J., Ford, I. , Kalra, L., Wardlaw, J. and Muir, K. W. (2019) Observer agreement on CT Perfusion imaging in acute ischemic stroke. Stroke, 50(11), pp. 3108-3114. (doi: 10.1161/STROKEAHA.119.026238) (PMID:31928512) (PMCID:PMC6824508)

Kalladka, D., Sinden, J., McLean, J., Moreton, F. C., Huang, X. and Muir, K. W. (2019) Increased deep grey matter functional connectivity of poststroke hNSC implanted ipsilesional putamen. Journal of Neurology, Neurosurgery and Psychiatry, 90(8), pp. 959-960. (doi: 10.1136/jnnp-2018-319022) (PMID:30530567)

Al-Shahi Salman, R. et al. (2019) Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial. Lancet Neurology, 18(7), pp. 643-652. (doi: 10.1016/S1474-4422(19)30184-X) (PMID:31129065)

Al-Shahi Salman, R. et al. (2019) Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial. Lancet, 393(10191), pp. 2613-2623. (doi: 10.1016/S0140-6736(19)30840-2) (PMID:31128924) (PMCID:PMC6617509)

Al-Shahi Salman, R. et al. (2018) The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial. Trials, 19, 162. (doi: 10.1186/s13063-018-2542-6) (PMID:29506580) (PMCID:PMC5838871)

Huang, X., Kalladka, D., Cheripelli, B. K., Moreton, F. C. and Muir, K. W. (2017) The impact of CT perfusion threshold on predicted viable and nonviable tissue volumes in acute ischaemic stroke. Journal of Neuroimaging, 27(6), pp. 602-606. (doi: 10.1111/jon.12442) (PMID:28414895)

Moreton, F. C., Düring, M., Phan, T., Srikanth, V., Beare, R., Huang, X., Jouvent, E., Chabriat, H., Dichgans, M. and Muir, K. W. (2017) Arterial branching and basal ganglia lacunes: a study in pure small vessel disease. European Stroke Journal, 2(3), pp. 264-271. (doi: 10.1177/2396987317718450)

Bivard, A. et al. (2017) Tenecteplase in ischemic stroke offers improved recanalization: analysis of 2 trials. Neurology, 89(1), pp. 62-67. (doi: 10.1212/WNL.0000000000004062) (PMID:28576782)

Bivard, A. et al. (2017) Impact of computed tomography perfusion imaging on the response to tenecteplase in ischemic stroke: analysis of two randomized controlled trials. Circulation, 135(5), pp. 440-448. (doi: 10.1161/CIRCULATIONAHA.116.022582) (PMID:27965285)

El Tawil, S., Cheripelli, B., Huang, X., Moreton, F., Kalladka, D., MacDougal, N. J.J., McVerry, F. and Muir, K. W. (2016) How many stroke patients might be eligible for mechanical thrombectomy? European Stroke Journal, 1(4), pp. 264-271. (doi: 10.1177/2396987316667176)

Cheripelli, B. K., Huang, X., MacIsaac, R. and Muir, K. W. (2016) Interaction of recanalization, intracerebral hemorrhage, and cerebral edema after intravenous thrombolysis. Stroke, 47(7), pp. 1761-1767. (doi: 10.1161/STROKEAHA.116.013142) (PMID:27301943)

Huang, X. et al. (2016) Tenecteplase versus alteplase in stroke thrombolysis: an individual patient data meta-analysis of randomized controlled trials. International Journal of Stroke, 11(5), pp. 534-543. (doi: 10.1177/1747493016641112) (PMID:27048693)

Cheripelli, B. K., Huang, X., McVerry, F. and Muir, K. (2016) What is the relationship among penumbra volume, collaterals, and time since onset in the first 6 h after acute ischemic stroke? International Journal of Stroke, 11(3), pp. 338-346. (doi: 10.1177/1747493015620807) (PMID:26763919)

Huang, X., Moreton, F., Kalladka, D., Cheripelli, B. K., Macisaac, R., Tait, R. C. and Muir, K. (2015) Coagulation and fibrinolytic activity of tenecteplase and alteplase in acute ischemic stroke. Stroke, 46(12), pp. 3543-3546. (doi: 10.1161/strokeaha.115.011290) (PMID:26514192)

Huang, X., Cheripelli, B. K., Lloyd, S. M. , Kalladka, D., Moreton, F. C., Siddiqui, A., Ford, I. and Muir, K. W. (2015) Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST): phase 2 randomised clinical trial. Lancet Neurology, 14(4), pp. 368-376. (doi: 10.1016/S1474-4422(15)70017-7) (PMID:25726502)

Ramani, L., Huang, X., Cheripelli, B. and Muir, K. W. (2015) Intravenous thrombolysis for acute stroke: current standards and future directions. Current Treatment Options in Cardiovascular Medicine, 17(3), 16. (doi: 10.1007/s11936-015-0373-2) (PMID:25778425)

This list was generated on Fri Aug 7 04:13:10 2020 BST.

Supervision

No staff ID in DB